Login / Signup

The impact of sirolimus therapy on lesion size, clinical symptoms, and quality of life of patients with lymphatic anomalies.

Michio OzekiAkifumi NozawaShiho YasueSaori EndoRyuta AsadaHiroya HashimotoToshiyuki Fukao
Published in: Orphanet journal of rare diseases (2019)
UMIN Clinical Trials Registry, UMIN000016580 . Registered 19 February 2015.
Keyphrases
  • clinical trial
  • lymph node
  • phase ii
  • stem cells
  • physical activity
  • depressive symptoms